Motoi Kondo
- Hepatology top 2%
- Oncology top 10%
- Molecular Biology
- Cancer Research top 5%
- Surgery top 10%
- Co-authors
- Keizo DonoMorito MondenMasato SakonKoji UmeshitaHiroaki NaganoShoji NakamoriAtsushi MiyamotoHirofumi Yamamoto
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (10 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers)interferon and immune responses (5 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Motoi Kondo
33 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 67
- Hepatology 470
- Oncology 433
- Molecular Biology 419
- Cancer Research 359
- Surgery 314
Countries citing papers authored by Motoi Kondo
This map shows the geographic impact of Motoi Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motoi Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motoi Kondo more than expected).
Fields of papers citing papers by Motoi Kondo
This network shows the impact of papers produced by Motoi Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motoi Kondo. The network helps show where Motoi Kondo may publish in the future.
Co-authorship network of co-authors of Motoi Kondo
This figure shows the co-authorship network connecting the top 25 collaborators of Motoi Kondo. A scholar is included among the top collaborators of Motoi Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motoi Kondo. Motoi Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 12 | |
| 3 | 4 | |
| 4 | 114 | |
| 5 | 35 | |
| 6 | 3 | |
| 7 | 95 | |
| 8 | 50 | |
| 9 | 111 | |
| 10 | 0 | |
| 11 | 0 | |
| 12 | 6 | |
| 13 | 3 | |
| 14 | 29 | |
| 15 | 106 | |
| 16 | 1 | |
| 17 | 19 | |
| 18 | 28 | |
| 19 | 11 | |
| 20 | 58 |
About Motoi Kondo
Motoi Kondo is a scholar working on Hepatology, Oncology and Cancer Research, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and interferon and immune responses (5 papers). The work is most often cited by research in Hepatology (470 citations), Cancer Research (359 citations) and Oncology (433 citations). Motoi Kondo has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Keizo Dono, Morito Monden, Masato Sakon, Koji Umeshita, Hiroaki Nagano, Shoji Nakamori, Atsushi Miyamoto, Hirofumi Yamamoto, Bazarragchaa Damdinsuren and Hideo Ôta. Their work appears in journals such as Gastroenterology, Hepatology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.